Half-times of irradiation recovery in accelerated partialbreast irradiation: Incomplete recovery as a potentially dangerous enhancer of radiation damage
Journal Title: Journal of Cancer Research & Therapy - Year 2013, Vol 1, Issue 10
Abstract
Purpose: To compare clinical results from accelerated partial breast irradiation with predictions from different half-times of recovery of radiation damage. Method: Three published results of excessive late complications led to an editorial which was a “wake up call” to the possible hazards of fractions spaced close together such as two fractions of 3.85 Gy a day on five consecutive days. These results are re-examined here using linear quadratic modelling with mono-exponential and bi-exponential recovery kinetics. Results: Although clinical results showed rather high proportions of severe complications, only in one of the three studies discussed in reference [1] complications were severe enough to cause it to be terminated. Since then other studies with the same doses have reported acceptable results. However, none of these complication rates are predicted to be tolerable, if mono-exponential kinetics with a single T ½ of ~4 hours is assumed. Conclusions: Better matches to clinical results can be found by assuming bi-exponential recovery with 50%-50% components of 0.3 hand 4 h, and α/β = 3 Gy, for late complications. There is continuing need for data from more clinical results, especially concerning various tumour types.
Authors and Affiliations
Fowler JF
Keywords
Related Articles
- EP ID EP551838
- DOI 10.14312/2052-4994.2013-35
- Views 61
- Downloads 0
Combined treatment of gemcitabine with indole-3-carbinol or metformin on drug efficacy in pancreatic cancer cell lines: The role of human equilibrative nucleoside transporters
Pancreatic cancer is one of the most lethal carcinomas in the United States. In accord with the American Cancer Society pancreatic cancer is anticipated to move from the third to the second leading cause of deaths in the...
The prevention and treatment of peritoneal carcinomatosis from gastric cancer: A 2013 update
Gastric cancer is the fourth most common cancer and the second leading cause of cancer death in the world. Penetration of the gastric serosa and lymphatic spread are the two most important factors affecting prognosis in...
Prognostic serum biomarkers for colorectal cancer – Review
Background: Colorectal cancer (CRC) is one of the most common malignancies in developed countries. Research for diagnostic and prognostic biomarkers is increasing. There are more than 750,000 papers indexed in PubMed dir...
Calcification of peritoneum and peritoneal fluid perfusion malfunction in carcinomatosis of serous membranes of peritoneal cavity
The article describes the peritoneal calcification in peritoneal carcinomatosis, as well as its possible role in the development of carcinomatosis within the frames of the authors’ alternative theory. The analysis of the...
In vitro and in vivo evaluation of tubulin inhibitors with non-small cell lung cancer pre-clinical models
Synthetic small molecule tubulin inhibitors have many advantages as novel anti-cancer agents compared to the current tubulin inhibitors generated from natural products. Our previous studies led to the design and synthesi...